Protembis
ApprovedTAVR procedures can cause large brain infarcts, which may lead to procedural clinical stroke and an increased risk of future stroke, cognitive decline, and dementia.
Founded
2013
Focus
CardiovascularMedical Devices
About
TAVR procedures can cause large brain infarcts, which may lead to procedural clinical stroke and an increased risk of future stroke, cognitive decline, and dementia.
Funding History
2Total raised: $12.5M
Series A$10MAndera PartnersMar 15, 2023
Seed$2.5MHigh-Tech GründerfondsJun 15, 2021
Company Info
TypePrivate
Founded2013
LocationAachen, Germany
StageApproved
Contact
Sectors
SIMILAR COMPANIES
300Microns
Pre-clinical · Munich
BetaSense
Pre-clinical · Berlin
AB Diagnostic Systems
Pre-clinical · Jena
bbi-biotech
Pre-clinical · Berlin
Mireca Medicines
Pre-clinical · Munich
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile